| Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) | Phase 3 | Anthos Therapeutics, Inc. | American Fork |
| AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications | Phase 3 | Novo Nordisk A/S | Bountiful |
| Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin | Phase 3 | AstraZeneca | Clearfield |
| Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation | Phase 2 | Regeneron Pharmaceuticals | Clinton |
| Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation | Phase 3 | Regeneron Pharmaceuticals | Clinton |
| A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) | Phase 3 | Colorado Prevention Center | Layton |
| A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists | Phase 3 | Colorado Prevention Center | Layton |
| OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events | Phase 3 | Amgen | Layton |
| Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry | — | QuesGen Systems Inc | Lehi |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity | Phase 3 | Novo Nordisk A/S | Murray |
| A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation | N/A | Biosense Webster, Inc. | Murray |
| A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation | Phase 2 | Novartis Pharmaceuticals | Murray |
| A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk | Phase 3 | Eli Lilly and Company | Murray |
| AMEND TS Early Feasibility Study | N/A | Valcare Medical Ltd. | Murray |
| ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ | N/A | JenaValve Technology, Inc. | Murray |
| Abbott Cephea Mitral Valve Disease Registry | — | Abbott Medical Devices | Murray |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase 3 | Icahn School of Medicine at Mount Sinai | Murray |
| Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease | — | University of Utah | Murray |
| COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction | N/A | Edwards Lifesciences | Murray |
| Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure | N/A | Procyrion | Murray |
| Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial | N/A | Edwards Lifesciences | Murray |
| Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy | Phase 4 | Dennis M. McNamara, MD, MS | Murray |
| Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention | Phase 4 | Duke University | Murray |
| Medtronic Terminate AF Study | N/A | Medtronic Cardiac Surgery | Murray |
| PARTNER 3 Trial - Aortic Valve-in-Valve | N/A | Edwards Lifesciences | Murray |
| Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) | N/A | Supira Medical | Murray |
| Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II | N/A | AliveCor | Murray |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction | Phase 3 | Cytokinetics | Murray |
| The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves). | N/A | Mayra Guerrero | Murray |
| WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department | N/A | Ohio State University | Murray |
| : Vascular Function in Health and Disease | Phase 1 | D. Walter Wray | Salt Lake City |
| A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury | — | University of Utah | Salt Lake City |
| A Phase 2 Study of CRD-4730 in CPVT | Phase 2 | Cardurion Pharmaceuticals, Inc. | Salt Lake City |
| A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study | N/A | Carelon Research | Salt Lake City |
| A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment | — | Ipsen | Salt Lake City |
| A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections | Phase 3 | X4 Pharmaceuticals | Salt Lake City |
| A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction | Phase 3 | Bayer | Salt Lake City |
| A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction | Phase 3 | Bayer | Salt Lake City |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | Phase 3 | Boehringer Ingelheim | Salt Lake City |
| A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Imbria Pharmaceuticals, Inc. | Salt Lake City |
| ATrial Tachycardia PAcing Therapy in Congenital Heart | — | Ian Law | Salt Lake City |
| Abatacept in Immune Checkpoint Inhibitor Myocarditis | Phase 3 | Massachusetts General Hospital | Salt Lake City |
| Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant | Phase 3 | Eidos Therapeutics, a BridgeBio company | Salt Lake City |
| An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis | Phase 2 | Zomagen Biosciences Ltd. | Salt Lake City |
| Anticoagulation in ICH Survivors for Stroke Prevention and Recovery | Phase 3 | Yale University | Salt Lake City |
| Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study | Phase 2/3 | Kardigan, Inc. | Salt Lake City |
| BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease | N/A | Carelon Research | Salt Lake City |
| BOdygUardian MOnitoriNg for ReCurrencE of AF | — | Heart Rhythm Clinical and Research Solutions, LLC | Salt Lake City |
| CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) | N/A | VA Office of Research and Development | Salt Lake City |
| Cardiac Sarcoidosis Randomized Trial | Phase 3 | Ottawa Heart Institute Research Corporation | Salt Lake City |
| CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) | Phase 3 | Cardiol Therapeutics Inc. | Salt Lake City |
| Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator | Phase 4 | University of Rochester | Salt Lake City |
| Comparing the Safety and Efficacy of Apixaban and Rivaroxaban | Phase 4 | VA Office of Research and Development | Salt Lake City |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | N/A | Weill Medical College of Cornell University | Salt Lake City |
| Cord Clamping Among Neonates With Congenital Heart Disease | N/A | Carl Backes, MD | Salt Lake City |
| Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation | — | University of Alberta | Salt Lake City |
| Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements | N/A | University of California, Davis | Salt Lake City |
| EFS of the DUO System for Tricuspid Regurgitation | N/A | CroiValve Limited | Salt Lake City |
| FORWARD CAD IDE Study | N/A | Shockwave Medical, Inc. | Salt Lake City |
| Fontan Udenafil Exercise Longitudinal Assessment Trial - 2 | Phase 3 | Mezzion Pharma Co. Ltd | Salt Lake City |
| GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study | N/A | W.L.Gore & Associates | Salt Lake City |
| Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation | N/A | University of Pennsylvania | Salt Lake City |
| Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future | — | International Consortium of Circulatory Assist Clinicians | Salt Lake City |
| Hydrogen's Feasibility and Safety as a Therapy in ECPR | Phase 1 | Boston Children's Hospital | Salt Lake City |
| INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery | N/A | Abiomed Inc. | Salt Lake City |
| Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure | N/A | University of Colorado, Denver | Salt Lake City |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | Salt Lake City |
| Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure | N/A | BrioHealth Solutions, Inc. | Salt Lake City |
| LVAD Conditioning for Cardiac Recovery | N/A | STAVROS G DRAKOS | Salt Lake City |
| Left vs Left Randomized Clinical Trial | N/A | Baylor College of Medicine | Salt Lake City |
| Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US) | — | Mirum Pharmaceuticals, Inc. | Salt Lake City |
| National Collaborative to Improve Care of Children With Complex Congenital Heart Disease | — | Children's Hospital Medical Center, Cincinnati | Salt Lake City |
| Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | N/A | University of Michigan | Salt Lake City |
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | — | Duke University | Salt Lake City |
| Physiology of Unloading VA ECMO Trial | Phase 2 | University of Utah | Salt Lake City |
| Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD) | N/A | Carelon Research | Salt Lake City |
| Product Surveillance Registry | — | Medtronic | Salt Lake City |
| Randomized Trial of SGLT2i in Heart Transplant Recipients | Phase 4 | VA Office of Research and Development | Salt Lake City |
| Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias | — | Heart Rhythm Clinical and Research Solutions, LLC | Salt Lake City |
| RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring | Phase 2 | University of Utah | Salt Lake City |
| Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT | N/A | Thermedical, Inc. | Salt Lake City |
| Simulation Trial of Telemedical Support for Paramedics | N/A | Boston Medical Center | Salt Lake City |
| Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia | Phase 3 | Novartis Pharmaceuticals | Salt Lake City |
| Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia | Phase 3 | Novartis Pharmaceuticals | Salt Lake City |
| Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function | Phase 3 | AstraZeneca | Salt Lake City |
| TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy | Phase 3 | Alnylam Pharmaceuticals | Salt Lake City |
| The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR | N/A | Cardiac Dimensions, Inc. | Salt Lake City |
| The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study | N/A | Brigham and Women's Hospital | Salt Lake City |
| The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | Phase 3 | Johns Hopkins University | Salt Lake City |
| Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders | Phase 3 | Ascendis Pharma A/S | Salt Lake City |
| Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure | N/A | Abbott Medical Devices | Salt Lake City |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | West Valley City |